- Home
- CKPT vs ALTG Comparison
CKPT vs ALTG Comparison
Compare CKPT & ALTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CKPT
- ALTG
- Stock Information
- Founded
- CKPT 2014
- ALTG 1984
- Country
- CKPT United States
- ALTG United States
- Employees
- CKPT N/A
- ALTG N/A
- Industry
- CKPT Biotechnology: Pharmaceutical Preparations
- ALTG Industrial Machinery/Components
- Sector
- CKPT Health Care
- ALTG Industrials
- Exchange
- CKPT Nasdaq
- ALTG Nasdaq
- Market Cap
- CKPT 172.4M
- ALTG 165.4M
- IPO Year
- CKPT 2017
- ALTG N/A
- Fundamental
- Price
- CKPT $4.04
- ALTG $4.70
- Analyst Decision
- CKPT Buy
- ALTG Buy
- Analyst Count
- CKPT 3
- ALTG 3
- Target Price
- CKPT $4.33
- ALTG $13.50
- AVG Volume (30 Days)
- CKPT 5.6M
- ALTG 303.4K
- Earning Date
- CKPT 03-28-2025
- ALTG 03-05-2025
- Dividend Yield
- CKPT N/A
- ALTG 4.87%
- EPS Growth
- CKPT N/A
- ALTG N/A
- EPS
- CKPT N/A
- ALTG N/A
- Revenue
- CKPT $41,000.00
- ALTG $1,876,600,000.00
- Revenue This Year
- CKPT $102,182.93
- ALTG $3.75
- Revenue Next Year
- CKPT $351.71
- ALTG $5.70
- P/E Ratio
- CKPT N/A
- ALTG N/A
- Revenue Growth
- CKPT N/A
- ALTG N/A
- 52 Week Low
- CKPT $1.38
- ALTG $4.35
- 52 Week High
- CKPT $4.50
- ALTG $13.67
- Technical
- Relative Strength Index (RSI)
- CKPT 65.90
- ALTG 37.98
- Support Level
- CKPT $2.37
- ALTG $4.72
- Resistance Level
- CKPT $4.07
- ALTG $5.00
- Average True Range (ATR)
- CKPT 0.03
- ALTG 0.39
- MACD
- CKPT 0.01
- ALTG 0.02
- Stochastic Oscillator
- CKPT 70.00
- ALTG 19.55
About CKPT Checkpoint Therapeutics Inc.
Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its lead small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor ("EGFR") inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.
About ALTG Alta Equipment Group Inc.
Alta Equipment Group Inc is an integrated equipment dealership platform in the U.S. Its segments are Material Handling and Construction Equipment. The Material Handling segment is engaged in operations related to the sale, service, and rental of lift trucks in Michigan, Illinois, Indiana, New York, Virginia, and throughout the New England states whereas, the Construction Equipment segment is principally engaged in operations related to the sale, service, and rental of construction equipment in Michigan, Indiana, Illinois, Ohio, New York, Florida and throughout the New England States.